baber/WOPTO huggingface dataset:
Patent DE-69528819-D1 (DE)
Inventor: FLINCK HANNU
IPC: H04Q11/04
Filed: 1995-01-13
Granted: 2002-12-19
Abstract: PCT No. PCT/FI95/00012 Sec. 371 Date Jul. 16, 1996 Sec. 102(e) Date Jul. 16, 1996 PCT Filed Jan. 13, 1995 PCT Pub. No. WO95/19674 PCT Pub. Date Jul. 20, 1995A method and system for controlling a statistically multiplexed ATM bus, to the bus being connected a bus controller and interface units for transmission of packets, i.e. cells, over the bus, in which, having detected, for each cell to be transmitted to an ATM bus, the address of the interface unit participating in the transmission, the bus controller sets the address on an address bus of the ATM bus, thereby activating transmission of the cell from the bus controller to the interface unit, or vice versa, over a data bus of the ATM bus. During the transmission of the cell, the bus controller fetches the next interface unit address for transmission of the next cell from or to the interface unit concerned.
Patent DE-69529617-D1 (DE)
Inventor: KIKINIS DAN
IPC: G09G5/18
Filed: 1995-09-11
Granted: 2003-03-20
Abstract: A system for adjusting signals to a CRT in a video monitor utilizes an interactive display having shapes that appear rectangular on a properly adjusted monitor and dragging handles associated with the shapes. Control routines executed on a host computer associate pointer position and movement in dragging the handles with creation of signals to be sent to the monitor to correct signals to the CRT to produce a properly sized, positioned, and shaped display. In one embodiment, digital values are placed in serial packets on a VSYNC line from the host to the video monitor, and a microcontroller in the monitor receives the digital values and drives circuitry in the monitor according to the received commands and data to adjust the signals to the CRT to correct the display.
Patent DE-69612024-D1 (DE)
Inventor: WIRTH DAVID D
IPC: C07H19/06
Filed: 1996-01-22
Granted: 2001-04-19
Abstract: A process for the preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine (VI) from 2-deoxy-2,2-difluoro- beta -D-ribo-pentopyranose (I). The process uses a tritylation reaction (Step 3) for preparing 2-deoxy-2,2-difluoro-5-O-triphenylmethyl-ribo-pentofuranose (II) as a key intermediate. The 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine (VI) is an antiviral and anti-cancer agent. <CHEM>
Patent DE-69617161-D1 (DE)
Inventor: GIBB DAVID
IPC: G07F5/18
Filed: 1996-09-25
Granted: 2002-01-03
Abstract: An open shelf bar arrangement for an hotel or like establishment comprises a plurality of open shelf bars (3), each having shelf units (23) for receiving articles (45) and control arrangements for determining the presence or absence of articles and transmitting data thereabout. A central processor (5) is provided for receiving data from the bar control arrangement of each bar (3) and for controlling the bars, the central processor (5) providing data to reporting means (11) for providing reports on the operation of the bars (3) and to a central billing arrangement (9) for adding the cost of items taken from the bars to appropriate customers billing. The invention also includes the bar control arrangement and the bar shelf units (23). <IMAGE>
Patent DE-69619156-D1 (DE)
Inventor: LAURENT PHILIPPE
IPC: A61P25/28
Filed: 1996-05-14
Granted: 2002-03-21
Abstract: Use of a cpd. of formula (I) selected from ( alpha -(tert.-butylaminomethyl)- 3,4-dichlorobenzyl)thioacetamide (Ia) and its laevorotatory (i.e. (-)) isomer, ( alpha -(tert.-amylaminomethyl)- 3,4-dichlorobenzyl)thioacetamide (Ib) and its isomers and ( alpha -(1-adamantylaminomethyl)- 3,4-dichlorobenzyl)thioacetamide (Ic) and its isomers, or their acid addn. salts, is claimed for the prepn. of a dopamine re-uptake inhibiting medicament. In the formula, R = tert.-butyl in (Ia), tert. amyl in (Ib) or 1-adamantyl in (Ic). Also claimed are (-)-(Ia) and its acid addn. salts (specifically the hydrochloride); (Ib) and its isomers and acid addn. salts; and (Ic) and its isomers and acid addn. salts are new cpds.
Patent DE-69620176-D1 (DE)
Inventor: TAO YANG
IPC: B07C5/342
Filed: 1996-06-07
Granted: 2002-05-02
Abstract: Image processing system using cameras and image processing techniques to identify undesirable objects on roller conveyor lines. The cameras above the conveyor capture images of the passing objects. The roller background information is removed and images of the objects remain. To analyze each individual object accurately, the adjacent objects are isolated and small noisy residue fragments are removed. A spherical optical transform and a defect preservation transform preserve any defect levels on objects even below the roller background and compensate for the non-lambertian gradient reflectance on spherical objects at their curvatures and dimensions. Defect segments are then extracted from the resulting transformed images. The size, level, and pattern of the defect segments indicate the degree of defects in the object. The extracted features are fed into a recognition process and a decision making system for grade rejection decisions. The locations in coordinates of the defects generated by a defect allocation function are combined with defect rejection decisions and user parameters to signal appropriate mechanical actions such as to separate objects with defects from those that are defect-free.
Patent DE-69621307-D1 (DE)
Inventor: LARDILLAT ALAIN
IPC: F24F13/24
Filed: 1996-10-29
Granted: 2002-06-27
Abstract: The ventilation duct consists of a casing (1) with an inner lining of insulation panels. The panels are made from a mineral, e.g. glass or rock wool, and have their inner surfaces (2a) protected by layers of glass fabric, with their exposed edges (2b) covered by the same material. The insulation panels are held in place inside the duct by lengthwise Z-section elements (3), each of which is positioned to cover at least part of a panel lengthwise edges and to overlap part of its flat inner surface. The Z-section elements can be in various configurations, e.g. with folded edges, and they can be cut and bent to follow bends in the ventilation duct. In addition, joints between the ends of insulation panels can be covered by T-section elements.
Patent DE-69622709-D1 (DE)
Inventor: CHIANG HERMAN
IPC: A63B33/00
Filed: 1996-09-04
Granted: 2002-09-05
Abstract: A swimming goggle structure (1) includes two frames (10, 11) each having a lens (14, 15) fixed therein with a bridge (12) connecting between inner sides of the frames. The bridge comprises a bendable insert (20) embedded therein and substantially extending across the bridge to provide conformity of the bridge to a wearer's nose contour. <IMAGE>
Patent DE-69637150-D1 (DE)
Inventor: KONIG GERHARD
IPC: A61P25/28
Filed: 1996-02-14
Granted: 2007-08-09
Abstract: The instant invention provides for monoclonal antibody which is specific for the ²A4 peptide, and in particular the free C-terminus of ²A4 "1-42" but not "1-43", and stains diffuse and fibrillar amyloid, vascular amyloid and neurofibrillary tangles. The instant invention further provides for antibody fragments and constructs thereof which have the same binding specificity. The instant invention also provides for methods of diagnosis, screening and therapeutics for treating unique forms of ²A4 peptide, using the antibodies of the instant invention.
Patent DE-69703256-D1 (DE)
Inventor: ITO FUMITAKA
IPC: C07D211/70
Filed: 1997-01-07
Granted: 2000-11-16
Abstract: A compound of the following formula: <CHEM>  and its pharmaceutically acceptable salt thereof, wherein   R<1> and R<2> are independently hydrogen, C1-4 alkyl, C3-7 cycloalkyl, C2-4 alkenyl, C1-4 alkoxy-C1-4 alkyl, C1-4 alkylthio-C1-4 alkyl, phenyl, phenyl-C1-4alkyl, halo-substituted C1-4 alkyl, C3-7 cycloalkyl-C1-3 alkyl or hydroxy-C1-4alkyl ; or R<1> and R<2> are taken together with the nitrogen to which they are attached and form optionally substituted, saturated or unsaturated 3-, 4-, 5-, 6- or 7- membered heterocyclic cantaining one to two heteroatoms, provided that the heterocyclic is not pyrrolidinyl;   R<3> is   hydrogen, C1-4 alkyl or a hydroxy protecting group; Ar is   optionally substituted phenyl or phenyl-C1-3 alkyl; and X is   optionally substituted phenyl, naphthyl, biphenyl, indanyl, benzofuranyl, benzothiophenyl, 1-tetralone-6-yl, C1-4 alkylenedioxy, pyridyl, furyl or thienyl.     These compounds and pharmaceutical compositions containing them are useful as analgesic, antiinflammatory, diuretic, antitussive, anesthetic or neuroprotective agents, or an agent for treatment of stroke or functional bowel disease such as abdominal pain, for the treatment of a mammalian subject, especially a human subject.
Patent DE-69713381-D1 (DE)
Inventor: SCHACHT ETIENNE HONORE
IPC: A61K47/48
Filed: 1997-11-06
Granted: 2002-07-18
Abstract: Synthetic polymer-based carrier vehicles for delivery of nucleic acid material to target cells in biological systems are made by self-assembly of the nucleic acid with cationic polymer material so as to condense the nucleic acid and form a polyelectrolyte complex and reacting the complex with hydrophilic polymer material which bonds to the complex forming a hydrophilic coating that stabilizes the complex and provides an outer protective steric shield. The carrier vehicles are useful for gene therapy.
Patent DE-69736663-D1 (DE)
Inventor: PERDOMI GIANNI
IPC: B32B7/02
Filed: 1997-12-08
Granted: 2006-10-26
Abstract: The invention concerns a thermoshrinking film consisting essentially of: a) a layer A of low density polyethylene; b) a layer B made from a composition comprising: 73 to 95 % by weight of a copolymer (i) of ethylene with at least one  alpha -olefin CH2=CHR where R is an alkyl radical having 1 to 10 carbon atoms, said copolymer having density between 0.920 and 0.960 g/cm<3> and a content of  alpha -olefin CH2=CHR derived units up to 10 % by mole; 5 to 27 % by weight of a copolymer (ii) of propylene with ethylene and/or at least one  alpha -olefin CH2=CHR<I>, where R<I> is an alkyl radical having 2 to 10 carbon atoms; said copolymer containing 60 to 98 % by weight of propylene, said copolymer being characterized by a xylene insoluble fraction higher than 70 % by weight; said composition forming layer B having density between 0.915 and 0.950 g/cm<3>, Melt Index E between 0.1 and 2 g/10' and Melt Flow Ratio lower than 50. The film of the invention is particularly suitable for overwrapping low density polyethylene sacks, since heating to induce shrinking does not cause the adhesion of the film to the sacks.
Patent DE-69739356-D1 (DE)
Inventor: CHENCHIK ALEX
IPC: C12N15/10
Filed: 1997-01-03
Granted: 2009-05-28
Abstract: Described are compositions and methods which allow for the efficient addition of a defined sequence at the 3'-end of a full-length cDNA in the course of first-strand cDNA synthesis from an mRNA template. A cDNA synthesis primer that is capable of annealing to mRNA is used to prime the first strand synthesis reaction. An oligonucleotide that is linked to the 5'-end of the mRNA serves as a short, extended template such that when the reverse transcriptase enzyme reaches the 5'-end of the mRNA, the enzyme switches templates and proceeds to transcribe through the end of the linked oligonucleotide. As a result, the single-stranded cDNA product which corresponds to the full-length mRNA, will have at the 3'-end a defined sequence which is complementary to the linked oligonucleotide. A conservative element in the oligonucleotide sequence responsible for this reaction can include 3 to 5 guanylic acid residues at the 3'-end of the oligonucleotide. The subject invention provides for the increased synthesis of full-length cDNA from mRNA templates. The full-length cDNA prepared according to the present invention can then be amplified using PCR or cloned using standard procedures.
Patent DE-69812887-D1 (DE)
Inventor: WATTS JAMES
IPC: A61K9/16
Filed: 1998-01-14
Granted: 2003-05-08
Abstract: A drug delivery composition for nasal administration is provided which comprises the antiviral agent ICAM-1 and a bioadhesive material. The bioadhesive material may be a chitosan solution, a liquid formulation comprising a polymeric material or a plurality of bioadhesive microspheres. The polymeric material is preferably gellan gum or alginate. The microspheres may comprise starch, chitosan, hyaluronic acid, or gelatin.
Patent DE-69814353-D1 (DE)
Inventor: CRUSE W
IPC: C08K5/5419
Filed: 1998-08-21
Granted: 2003-06-12
Abstract: This invention describes novel blocked mercaptosilanes wherein the hydrogen atom of the mercaptan functionality has been substituted. The invention includes methods of preparation for the blocked mercaptosilicon compounds as well as their use in filled rubbers. The blocked mercaptosilanes described are unique in that they allow the mixing of fillers with organic polymers to proceed while remaining inert toward coupling to the polymer. The coupling reactions of these blocked mercaptosilicon compounds are triggered by addition of an appropriate deblocking agent.
Patent DE-69815350-D1 (DE)
Inventor: ROZ THIERRY
IPC: H04B1/59
Filed: 1998-11-03
Granted: 2003-07-10
Abstract: The transponder (30) has an antenna (32) to exchange a radio signal (34), a processor (36), and accumulator (38) to provide electric supply (V1), and a capacitor storage (40) for energy from the received radio signal to provide a second supply (V2). The supply levels are compared (42,46) to a threshold value (Vmin) which sends control signals (V3,V4) to the charging circuit (50).
Patent DE-69817910-D1 (DE)
Inventor: KATSUDA NOBUYUKI
IPC: B60R21/26
Filed: 1998-04-23
Granted: 2003-10-16
Abstract: To provide a gas generator for an air bag which enables a gas generating agent to be completely burned in a desired period of time, and shows sufficient operating characteristics. In a gas generator for an air bag wherein igniting means to be actuated when an impact sensor detects an impact, solid bodies of gas generating agent to be ignited by the igniting means and burned to generate a combustion gas, and filter means for cooling the combustion gas and scavenging combustion residues are accommodating in a housing having gas discharge ports, the ratio (A/At) of the total surface area A of the solid bodies of gas generating agent to the total opening area At of the gas discharge ports is controlled to be larger than 300.
Patent DE-69820480-D1 (DE)
Inventor: SENNI KARIM
IPC: A61K36/02
Filed: 1998-12-17
Granted: 2004-01-22
Abstract: The invention concerns the use of fucanes for obtaining medicines for modulating metalloprotease and inhibiting leukocytic elastase. Said medicines help activate collagen synthesis inhibit proliferation of gingival fibroblasts, and activate proliferation of dermal fibroblasts. They are useful in particular for treating periodontal pathologies and dermal lesions.
Patent DE-69821025-D1 (DE)
Inventor: TOBACK F GARY
IPC: C12N5/06
Filed: 1998-05-22
Granted: 2004-02-12
Abstract: Novel growth peptides derived from protein factors having molecular weights of about 22 and 45 kDa stimulate mitogenic activity of epithelial, but not fibroblastic cells, in particular, kidney epithelial cells. A source of the factors is scrape-wounded kidney epithelial cells in culture. Synthetic peptides having sixteen amino acids or less, in particular a hexapeptide, YPQGNH (SEQ ID NO: 2) maintain the mitogenic activity. The peptide AQPYPQGNHEASYG (14-Ser) (SEQ ID NO: 15) is effective in reversing acute renal failure in animals. The growth-promoting characteristics of the 22 and 45 kDa proteins and the peptides are useful in treating and diagnosing patients with kidney disease. Nucleotide sequences that encode the factor are useful to develop probes to locate similar factors, to identify genetic disorders involving the factor, and to produce the factor by genetic recombinant methods. The nucleotide sequences and fragments thereof, are also useful for diagnosis and treatment of kidney disorders.
Patent DE-69827127-D1 (DE)
Inventor: LEROY ODILE
IPC: A61K47/48
Filed: 1998-05-14
Granted: 2004-11-25
Abstract: The invention concerns a pharmaceutical composition for treating or preventing a certain number of infections caused by pathogenic agents such as bacteria, comprising as immunogen, one or several polyosides derived from one or several pathogenic agents. The polyosides are in the form of conjugates, coupled with a carrier protein. The composition contains at least two types of conjugates, each being at least characterised by a different protein carrier.
Patent DE-69834404-D1 (DE)
Inventor: GRASSETTI DAVIDE R
IPC: A61P35/00
Filed: 1998-08-05
Granted: 2006-06-08
Abstract: A method of treating a human subject to inhibit mutagenic effects of carcinogens by administering to the subject a composition comprising a sufficient amount of 6,6'-dithiodinicotinic acid to inhibit activity of poly(ADP-ribose) polymerase in said subject to thereby inhibit said effects. Also provided is a method of inhibiting occurrence of mutations and of cancers derived from mutations, which method comprises administration to a subject of a composition comprising a sufficient amount of 6,6'-dithiodinicotinic acid.
Patent DE-69839781-D1 (DE)
Title: Heterocyclische topoisomerase toxine
Inventor: LAVOIE EDMOND J
IPC: C07D235/20
Filed: 1998-12-30
Granted: 2008-09-04
Abstract: The invention provides compounds of formula I: wherein R<SUB>1 </SUB>to R<SUB>5 </SUB>have any of the values defined in the specification, as well as pharmaceutically acceptable salts of the compounds, pharmaceutical compositions comprising the compounds, and methods of using the compounds, compositions, or salts to treat cancer. In embodiments, R<SUB>4 </SUB>and R<SUB>5 </SUB>taken together can be a 3, 4, or 5 membered saturated or unsaturated chain comprising members selected from the group consisting of non-peroxide oxygen, sulfur, N(X), and carbon, optionally substituted by oxo; wherein each X is independently absent or is H, O, (C<SUB>1</SUB>-C<SUB>4</SUB>)alkyl, phenyl or benzyl; and wherein at least one of the chain members is an N-H group.
Patent DE-69903559-D1 (DE)
Inventor: KOKEN MARCEL
IPC: A61K33/36
Filed: 1999-07-30
Granted: 2002-11-21
Abstract: The invention concerns the use of novel agents including cell death, and in particular, an agent for overexpression of the PML protein on nuclear bodies, combined with interferons, to induce the death of undesirable cells and simulate an immune reaction.
Patent DE-69909053-D1 (DE)
Inventor: DOLHAY BALAZS
IPC: B63H21/175
Filed: 1999-01-25
Granted: 2003-07-31
Abstract: The invention relates to an amphibious caravan comprising a floating chassis with wheels and at least one cabin with a living compartment. The caravan has a vehicle deck receiving a towing vehicle. The vehicle deck is situated adjacent to the cabin. The caravan is equipped with a marine screw suitable for moving the caravan on the water. According to the invention, the cabin may be displaced substantially parallel to the longitudinal axis of the chassis, so that the length of the deck receiving the vehicle is variable.
Patent DE-69914198-D1 (DE)
Inventor: MARTINSON D
IPC: H03D7/00
Filed: 1999-06-11
Granted: 2004-02-19
Abstract: There is provided an image rejection mixer for downconversion of an incoming signal to a lower intermediate frequency signal, using the absolute difference of frequencies between the incoming signal and the local oscillator signal. The image rejection mixer is set up to accept and downconvert incoming signals at two discrete frequencies fh and fl, where the local oscillator frequency is positioned mid-way between those frequencies fh and fl. There are two signal paths in the image rejection mixer, either one or the other of which is chosen by positioning a controllable single pole, double throw switch into one of its two switch positions. The output of the switch is led to a mixing element, from which an intermediate frequency signal is derived. The first of the two signal paths from the input to the image rejection mixer to the mixing element has a bandpass characteristic centered at one or the other of the two input frequencies of interest; the other signal path has a bandstop characteristic centered at the same frequency. By choosing one or the other of the signal paths, an incoming signal at a designated one or the other of the incoming signal frequencies may be downconverted, and the image signal and any noise at that image signal frequency will be rejected.
Patent DE-69915430-D1 (DE)
Inventor: MEYER OLIVER
IPC: C07C69/65
Filed: 1999-09-23
Granted: 2004-04-15
Abstract: A process for the preparation of dialkyl phenylmalonates of formula I, <CHEM>  wherein R, R<1>, L<1> and L<2> have the meaning given in the claims,  which comprises  treating a phenylbromide of formula II <CHEM>  with a dialkyl malonate of formula III <CHEM>  in an inert solvent in the presence of a base and a copper salt, wherein 1.0 mole of the phenylbromide of formula II is treated with the enolate obtained from 2.0 to 4.0 moles of the dialkyl malonate of formula III and 2.0 to 3.8 moles of the base.
Patent DE-69916498-D1 (DE)
Inventor: ENGSTROEM SVEN-ERIK
IPC: F41A9/16
Filed: 1999-11-15
Granted: 2004-05-19
Abstract: The present invention relates to a method and a device for handling artillery shells (14-16) when loading artillery guns (1) that have an integral shell magazine (9) fixed in the traverse system but independent from the elevating mass, which magazine on command feeds out shells (14-16) one by one with a specific linear velocity in the longitudinal axis of each shell. Each shell is subsequently transferred to the loading position for the gun by a loading pendulum (13) and cradle (6). The basic idea behind the present invention is that the outfeed velocity of the shells (14-16) from the magazine (9) shall be braked to zero in a brake module (12) mounted on the gun while they lie in a shell carrier (17, 18) mounted on the loading pendulum (13). Immediately after the linear velocity of the shell has been braked to zero and its rear plane has been reversed to a pre-defined position the shell carrier (17, 18) takes over the handling of the shell and re-angles it to coincide with the angle of elevation of the gun, and transfers the shell to a laterally displaceable shell loading cradle (6).
Patent DE-69917453-D1 (DE)
Inventor: KERTTULA REIMA
IPC: D21F9/00
Filed: 1999-05-27
Granted: 2004-06-24
Abstract: The invention concerns an integrated paper machine, which comprises, in the running direction of the web, a multi-layer headbox (100), a gap former (200), in which there is at least one pre-press (303, 304), a press section (300), in whcih there is at least one extended-nip press (308, 309), a pre-dryer section (400), in which the web (W) is dried by means of a high-capacity dryer unit, a dryer section (500), in which there is at least one dryer group (R1, R2, R3) which makes use of single-wire draw, as well as a surface treatment device (P) for the web. Further, the paper machine is provided with a closed web draw at least to the end of the dryer section (500).